Pfizer Researchers Discuss Findings in Influenza Vaccines (Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines)

Source :: Proteomics Weekly. October 28, 2024, 727
Publication Year :: 2024
Abstract: 2024 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Proteomics Weekly -- Research findings on influenza vaccines are discussed in a new report. According to news reporting [...]

Subjects :: Pfizer Inc. -- Safety and security measures
Vaccination -- Safety and security measures
Medical research -- Safety and security measures
Medicine, Experimental -- Safety and security measures
Influenza vaccines -- Safety and security measures
Influenza -- Prevention
Lectins -- Safety and security measures
Pharmaceutical industry -- Safety and security measures
Biotechnology industry
Business

Tools